Objective: To investigate the in vivo and in vitro effects of black tea on the oxidative modi®cation of low density lipoprotein (LDL). Design: The antioxidant activity of the tea was studied in vitro by measuring the resistance of the LDL to oxidative modi®cation in the presence of copper. The effects of tea consumption in vivo were investigated in two settings. Firstly, to assess the acute effects of tea consumption, ®ve fasting healthy subjects ingested 600 mls (50.7 AE 5.4 mg¯avonoids) of black tea and peripheral venous blood was collected at 0, 30, 60, 90, 120 and 180 min after consumption. Secondly, to assess the effects of chronic tea consumption, a randomised crossover trial of tea (126.8 AE 13.5 mg¯avonoids) and coffee consumption was carried out in ten healthy subjects. Results: Black tea extract increased the resistance of LDL in vitro in a concentration dependent manner. There was no signi®cant change in total plasma antioxidant capacity or susceptibility of the LDL to oxidation over the 3 h period after consumption of black tea. The four-week crossover study in which coffee was used as a control against the black tea showed no signi®cant difference in the total plasma antioxidant capacity or susceptibility of LDL to oxidation between the tea and coffee groups. Serum lipids, including total cholesterol, triglycerides, LDL cholesterol and HDL cholesterol did not change signi®cantly throughout the study. Conclusions: The consumption of moderate quantities of black tea acutely or for one week does not increase plasma total antioxidant capacity or alter the susceptibility of LDL to oxidation. Sponsorship: This work was funded by the Department of Agriculture for Northern Ireland.
Introduction
Flavonoids are a group of polyphenolic compounds widely distributed throughout the plant kingdom (Kuhnau et al, 1976) . They occur naturally in fruit and vegetables and are, therefore, an integral part of the human diet (Hertog et al, 1992 (Hertog et al, , 1993a . A number of epidemiological studies show an inverse correlation between dietary¯avonoid intake and mortality from coronary heart disease (CHD) (Hertog et al, 1993b (Hertog et al, , 1995 Knekt et al, 1996; Keli et al, 1996) . In the past, the dietary intake of¯avonoids in Western Europe was estimated to be in the range of 0.5±1.0 g per day, of which about 170 mg consisted of¯avonol,¯avonone and avone aglycones (Kuhnau et al, 1976) . More recently, however, it has been suggested that the actual intake is lower than this, around 25 mg of¯avonol (quercetin, kaempferol and myricetin) and¯avone (luteolin and apigenin) aglycones (Hertog et al, 1993b) .
The main sources of dietary¯avonoids are tea, onions, apples and red wine (Hertog et al, 1993b) . Tea is one of the most frequently consumed beverages in the world, with around 80% being consumed as black tea and the rest as green tea (Balentine, 1992) . The production of black tea involves a fermentation process to form a complex mix of catechin esters, thearubigens, thea¯avins and certain¯avo-nol glycosides. Recent epidemiological evidence suggests that increased black tea consumption may protect against stroke (Keli et al, 1996) . Conversely the Caerphilly Study found that increased tea consumption may increase susceptibility to heart disease (Hertog et al, 1997) .
It is currently believed that oxidative modi®cation of low density lipoproteins (LDL) by free radicals is a key early event in the pathogenesis of atherosclerosis (Steinberg et al, 1989) . The rapid uptake of oxidatively modi®ed LDL via a scavenger receptor leads to the formation of foam cells, and oxidised LDL also has a number of other atherogenic properties (Goldstein et al, 1979) . Several dietary¯avonoids have been shown to inhibit the oxidative modi®cation of LDL in vitro (de-Whalley et al, 1990) and hence, have the potential to reduce LDL oxidation and atherogenesis in vivo. However, the ef®ciency of the protection of LDL in vivo will depend on several factors, including the absorption of the¯avonoids and how they interact with lipoproteins. A number of mechanisms are likely to contribute to inhibition of LDL oxidation by¯avonoids. Flavonoids may directly scavenge some radical species, acting as chain-breaking antioxidants (deWhalley et al, 1990) . In addition, the¯avonoids may recycle other chain-breaking antioxidants such as a-tocopherol by donating a hydrogen atom to the tocopheryl radical (Frankel et al, 1993) . Transition metals such as iron and copper are important pro-oxidants; some¯avo-noids can chelate divalent metal ions, hence preventing free radical formation (de-Whalley et al, 1990) . Extensive in vitro studies have found most of the main dietary¯avo-noids to be effective in protecting against the oxidative modi®cation of LDL (de-Whalley et al, 1990; Laughton et al, 1991; Morel et al, 1993; Rankin et al, 1993; Igarashi & Ohmuma, 1995; Fuhrman et al, 1995) . Speci®cally, the ability of tea catechins to protect LDL against oxidative modi®cation has been investigated, with (7)-epigallocatechin (EGC), ()-catechin (C), (7)-epicatechin (EC), (7)-epicatechingallate (ECG) and (7)-epigallocatechingallate (EGCG) all having a signi®cantly protective effect (NegreSalvayre et al, 1991) .
Little information is available with regard to the absorption or metabolism of¯avonoids. In vivo studies to determine how effectively the polyphenols are absorbed from tea suggested a peak in plasma polyphenol concentration 60 min after ingestion (Takahama, 1985) . These ®ndings suggest that signi®-cant polyphenol absorption may occur following tea ingestion and point to a possible role of tea polyphenols in protecting LDL against oxidative modi®cation and consequently reducing atherogenesis. In view of this, the aim of the present study was to investigate the in vivo and in vitro effects of tea on the oxidative modi®cation of LDL.
Methods

Chemicals
All chemicals were purchased from Sigma Chemical Co., unless otherwise stated. All chemicals were b 95% pure except myricetin which was b 85%. Catechin, epicatechin, epicatechin gallate, epigallocatechin and epigallocatechin gallate were purchased from Apin Chemicals (Abingdon, Oxon).
Total antioxidant capacity assay solutions were purchased from Amersham International Ltd. (England). The study was carried out in accordance with the guidelines of the ethics committee of the Queen's University of Belfast.
Study design
The effects of tea consumption were investigated in two ways. Firstly, to assess the acute effects of tea consumption, ®ve fasting healthy subjects, four males and one female aged between 23 and 35 y, ingested 600 mls of black tea (Marks and Spencer Extra Strong Black tea) prepared as described below, and peripheral venous blood was collected at 0, 30, 60, 90, 120 and 180 min after consumption. Secondly, to assess the effects of chronic tea consumption, a randomised crossover trial of tea and coffee consumption was carried out by ten healthy subjects, six males and four females aged between 23 and 40 y. On days 1±7 of the study, subjects abstained from drinking tea or coffee. On day 7 subjects were randomised to drink 5 6 300 mls of black tea or coffee per day. This was followed by a one week`washout' period during which no tea or coffee was consumed and a ®nal one week period during which subjects crossed over to the other beverage. Fasting peripheral venous blood samples were taken at the end of each one week period.
Tea/Coffee preparation
The tea bags (mean 3.3 g) were infused for 4 min in a mug of boiling water as suggested by the manufacturer's instructions (Marks and Spencer Extra Strong Black Tea). Coffee was made by dissolving one teaspoon (mean 2.1 g) of coffee (Marks and Spencer Decaffeinated Coffee) in one mug of boiling water immediately before drinking. Standard mugs (volume of beverage ingested, 300 mls) were used throughout the study.
HPLC analysis
The chromatography was carried out using an Ultracarb ODS 20 C 18 (Phenomenex Ltd. UK) column (4.6 6 250 mm, 5mm) protected by an Ultracarb ODS 20 C 18 (Phenomenex Ltd. UK) guard column (4.6 6 30 mm, 5 mm). The HPLC system consisted of a TSP spectra system (Thermo Separation Products) P2000 pump, a TSP A1000 autoinjector and a TSP UV1000 detector set at 280 nm. The mobile phase used was acetic acid/methanol/dimethylformamide and water (1:10:35:154) with ā ow rate of 1 ml/min.
Catechin, epicatechin, epicatechin gallate, epigallocatechin and epigallocatechin gallate were all made up to a concentration of 500 mg/ml and stored at 4 C. Calibration curves ranging from 10±50 mg/ml were prepared for all the catechins. Samples were prepared by infusing tea bags for 4 min in 300 mls of boiling water. The aqueous tea extract was then ®ltered through a 0.2 mm supor acrodisc syringe ®lter, 50% methanol was added and the solution was analysed by HPLC. Quercetin, kaempferol and myricetin were quanti®ed using a different technique (Hertog et al, 1992) . In short, 15 ml of the aqueous tea extract was hydrolysed with 1.2 M HCl for 2 h at 90 C to hydrolyse the glycoside. The resulting aglycones were then quanti®ed using the same HPLC system. The mobile phase was ethanol/water (70/30) plus 1% acetic acid, and peaks were detected at 375 nm; calibration curves ranging from 1±10 mg/ml were prepared for quercetin, kaempferol and myricetin. Inter-assay c.v. was`10% for all¯avonoids, and intra-assay c.v.`8%.
LDL Oxidation
Plasma was obtained from heparinised blood samples by centrifugation at 1200 g for 10 mins at 4 C. LDL was isolated from the plasma by rapid ultracentrifugation and oxidised as previously described by McDowell et al (1995) . The protein concentration was standardised to 50 mg/l and oxidation was catalysed by copper (2 mmol/l) at 37 C. Conjugated diene formation was monitored at l 234 nm. The lag phase prior to the onset of rapid LDL oxidation is seen as a slope with a slow increase in absorbance. The duration of the lag phase is indicative of the resistance to oxidation of the LDL being examined. Inter-assay c.v.`5% and intra-assay c.v.`1%.
In vitro study of the effects of tea on LDL oxidation Aliquots (10 ml) of black tea (infusion the same as above) were freeze-dried. The in vitro antioxidant activity of the tea was then measured by adding increasing concentrations of the tea extract to the puri®ed LDL prior to oxidation (McDowell et al, 1995) . A second study was carried out with 5 mg/ml freeze dried tea extract being added to the crude LDL and incubated for 2 h at 4 C, before puri®cation by gel ®ltration and oxidation as described above.
Total antioxidant capacity assay
The total antioxidant capacity of plasma was assessed using the method described by Whitehead et al (1992) . In this method light emission occurs when the chemiluminescent substrate, luminol, is oxidised in the presence of the enhancer, p-iodophenol. The steady emission of light is dependent on the production of free radical intermediates within the reaction mixture. Light emission is, therefore, sensitive to interference by chain breaking antioxidants but will be restored when all such antioxidants have been consumed in the reaction. If the generation of radical intermediates is constant, then the time period of light suppression is directly related to the amount of chain breaking antioxidant present. The assay was calibrated against the water-soluble ascorbate and expressed in mmol/l ascorbate equivalents.
Cholesterol and triglycerides
Cholesterol and triglycerides were measured using standard (Kodak Ektachem, Clinical Chemistry Products) enzymatic techniques on a Kodak 750 XRC Ektachem analyser.
Results
HPLC analysis
The total increased intake of¯avonoids from the black tea was 126.8 AE 13.5 g per day based on the consumption of ®ve standard mugs per day ( Table 1) .
Effect of tea on LDL oxidation in vitro Black tea extract, when added to the LDL in vitro, increased the resistance of LDL to oxidation in a concentration dependent manner (Figure 1) . The lag phase, increased from 53 min up to 140 min at a concentration of 5 mg/ml of the freeze-dried extract. The rate of propagation decreased signi®cantly as the concentration of back tea extract was increased. Black tea extract, when incubated with LDL before puri®cation by gel ®ltration, did not protect the LDL from oxidation. The lag phase was 59.4 AE 4.48 min in the control samples and 63.7 AE 1.15 min in the samples containing 5 mg/ml freeze-dried tea extract (P b 0.05).
Acute effects of tea consumption
There was no signi®cant change in the susceptibility of the LDL to oxidation over the 3 h period after consumption of black tea (Figure 2 ). In addition, tea consumption had no signi®cant effect on the total plasma antioxidant capacity (Figure 3 ).
Chronic effects of tea consumption
The four week crossover study in which coffee was used as a control against the black tea showed no signi®cant difference in the total plasma antioxidant capacity between the tea and coffee groups (Figure 4 ). There was also no signi®cant difference in the susceptibility of LDL to oxidation following coffee or tea consumption ( Figure 5 ). Serum lipids, including total cholesterol, triglycerides, LDL cholesterol and HDL cholesterol did not change signi®cantly throughout the study (Figure 6 ).
Discussion
Epidemiological evidence has shown the intake of¯avo-noids to be inversely associated with the risk of coronary heart disease in elderly men. Black tea contributes around 60% of the total¯avonoid intake and recent epidemiological evidence suggests that the consumption of b 4.7 cups of black tea/day may protect against CHD (Keli et al, 1996) . The epidemiological evidence is however not completely clear; a study involving American male health workers (Rimm et al, 1996) found no correlation between¯avonoid intake and mortality from heart disease and recently the Caerphilly Study (Hertog et al, 1997) found a positive correlation between tea consumption and mortality from heart disease. The object of this study was, therefore, to assess whether the regular consumption of more than 4.7 cups per day of black tea, over a week, caused a rise in plasma antioxidants and/or protected the LDL from oxidation. The commercial tea used throughout all the studies was a rich source of avonoids (Table 1) and during both studies provided a signi®cant increase in estimated average daily intake (average estimated intake 25 mg/d (Hertog et al, 1993b) increased to 126.8 AE 13.5 mg/d throughout the chronic tea consumption study).
The initial in vitro experiment was designed to show whether or not the¯avonoids from the black tea could protect the LDL from oxidative modi®cation. Several mechanisms may contribute to the inhibition of LDL oxidation by¯avonoids, including metal chelation, a direct chain-breaking antioxidant effect, and recycling of the tocopheryl radical within the LDL particle (RiceEvans et al, 1996; . The addition of increasing concentrations of freeze-dried tea extract had a very highly signi®cant dose dependant effect on the LDL oxidation (Figure 1) , demonstrating that the antioxidants present in tea if absorbed in large enough quantities should be able to protect the LDL from oxidation in vivo. The following studies were carried out to see whether or not the tea¯avonoids are absorbed into the plasma at high enough quantities to cause a rise in total antioxidant capacity and protect the LDL from oxidative modi®cation in vivo.
Initially an acute consumption study was carried out to see how quickly the tea¯avonoids were absorbed into the plasma. After ingestion of 2 mugs (600 mls) of black tea, equivalent to 50.7 AE 5.4 mg total¯avonoid, total plasma antioxidant levels (Figure 3 ) did not change signi®cantly during the 3 h after ingestion, suggesting that tea¯avonoids made little contribution to plasma antioxidant capacity. There was also no change in the susceptibility of the LDL to oxidative modi®cation over the 3 h after ingestion suggesting the tea¯avonoids were not present in high enough quantities in the LDL at this time to provide a measurable change in susceptibility to oxidation. This might indicate that¯avonoids are not absorbed ef®ciently into the plasma after ingestion (Lee et al, 1995) . Alternatively, the incorporation of¯avonoids into LDL might require a longer period of time, given that the half life of LDL is 1±2 d. Therefore a chronic tea consumption study was carried out using a quantity of black tea suf®cient to increase total¯avonoid intake by 126.8 AE 13.5 mg/d. Coffee was used as a control as it has a negligible¯avonoid concentration (Hertog et al, 1993a) . However, even in this longer term study no signi®cant effect was found on total plasma antioxidant capacity or susceptibility of LDL to oxidation. A further in vitro experiment where tea extract was incubated with LDL which was then passed down a gel ®ltration column showed no signi®cant difference in oxidation parameters. The catechins from the tea were therefore not taken into the LDL particle ef®ciently enough to reduce oxidation. A number of studies (Maramatsu et al, 1986; Sheriff & Fakhri, 1988) have suggested that increased ingestion of tea reduced LDL cholesterol concentrations. The present study did not show any signi®cant effect on lipid parameters. There are two main strands of evidence supporting the hypothesis that¯avonoids protect against coronary heart disease. Firstly, a number of epidemiological studies have found there to be a negative correlation between¯avonoid intake and mortality from CHD. Some of these studies also found a negative correlation between tea, a beverage rich in avonoids, consumption and mortality from CHD. Secondly, almost all the dietary¯avonoids are capable of protecting LDL from oxidative modi®cation in vitro, a process considered to be of importance in the pathogenesis of atherosclerosis. There is, however, very little known about¯avonoid absorption and metabolism in vivo, and the extent of absorption of dietary¯avonoids remains an important unsolved problem in judging their potential health effects. He & Kies (1993) carried out a study indicating¯avonoids from black tea are at least partially absorbed. Lee et al (1995) found 176±554 ng/ml total catechins present in plasma 1 h after the ingestion of a cup of black tea containing 235 mg total catechins. They found maximum excretion of catechins 3±6 h after ingestion. Recent work by found it could take up to 24 h for the¯avonoids in plasma to return to baseline after ingestion. However, our results show that the ingestion of ®ve mugs (1.5 l equivalent to 126.78 AE 13.48 mg¯avonoids) of commercially available black tea a day for a week does not give a suf®cient rise in plasma antioxidant capacity to protect the LDL from oxidative modi®cation. It therefore seems likely that any cardioprotective effects of tea¯avonoids are attributable to mechanisms other than a reduction in the susceptibility of LDL to oxidation.
